Humana Reports Strong Q2 Earnings but Shares Drop in Pre-Market Trading
Despite reporting second-quarter earnings and revenue that beat Wall Street expectations, shares of Humana Inc. (NYSE:HUM) fell nearly 9% in pre-market trading on Wednesday. The health insurer reported adjusted earnings per share of $7.61 against a consensus estimate of $7.23, while quarterly revenue rose to $40.89 billion versus the expected $40.56 billion. Humana reaffirmed its full-year 2026 adjusted EPS guidance at least $9.00 but lowered its GAAP earnings outlook due to non-adjusted items. The company's Insurance segment reported a benefit ratio of 91.2%, in line with expectations, and it maintained its full-year insurance segment guidance. The stock decline occurred despite positive developments such as strong Medicare Advantage membership growth projections and the announcement that Humana won a new Medicaid contract in Illinois set to begin in early 2027.
Tickers: $HUM